SCHEMBL30501769

SCHEMBL30501769

CC(C)(C(=O)O)c1ccc(F)cc1F

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNN4 O15554 1/20 0.50
CES2 O00748 3/20 0.44
CES1 P23141 3/20 0.44
HDAC3 O15379 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
APP P05067 1/20 0.41
AKR1C3 P42330 2/20 0.40
AKR1C2 P52895 2/20 0.40
RIPK1 Q13546 2/20 0.39
GAA P10253 1/20 0.39
HTT P42858 1/20 0.39
LTB4R Q15722 1/20 0.38
LTB4R2 Q9NPC1 1/20 0.38
KMO O15229 2/20 0.38
RORC P51449 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2791382 1.00 KCNN4 (0.50) KCNN4CES2CES1HDAC3HDAC1
SCHEMBL25262844 0.85 CES2 (0.44) KCNN4CES2CES1APPAKR1C3
SCHEMBL8591922 0.83 KCNN4 (0.49) KCNN4CES2CES1HDAC3HDAC1
SCHEMBL29009855 0.83 KCNN4 (0.49) KCNN4CES2CES1HDAC3HDAC1
SCHEMBL6400375 0.83 KCNN4 (0.49) KCNN4CES2CES1HDAC3HDAC1
SCHEMBL8636721 0.81 KCNN4 (0.47) KCNN4CES2CES1HDAC3HDAC1
SCHEMBL1345677 0.81 PKM (0.42) KCNN4CES2CES1HDAC3HDAC1
SCHEMBL1625406 0.81 AKR1C3 (0.48) HDAC3HDAC1HDAC2HDAC6APP
SCHEMBL6229462 0.81 KCNN4 (0.51) KCNN4CES2CES1HDAC3HDAC1
SCHEMBL2793735 0.81 AKR1C3 (0.41) KCNN4APPAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4452964-A1 HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF CANCER Boehringer Ingelheim International GmbH (DE) 2024-10-30 EP disclosed
CN-118339153-A Heteroaromatic compounds for the treatment of cancer 勃林格殷格翰国际有限公司 2024-07-12 CN disclosed
WO-2023117681-A1 HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-06-29 WO disclosed